The Radiotherapy Market was valued at USD 7 billion in 2023, and is projected to reach USD 11.4 billion by 2032, rising at a CAGR of 5.7%. Radiotherapy plays a crucial role in cancer treatment by using high doses of radiation such as X-rays, gamma rays, or charged particles to damage the DNA of cancer cells, preventing their further growth and division. This treatment can be administered externally with a linear accelerator or internally by placing radioactive material near cancerous cells.
The rising incidence of cancer worldwide is a primary driver behind the market’s growth. Increasing awareness of advanced cancer treatments, including radiotherapy, is further supporting market expansion. Continuous technological advancements are improving the precision and efficiency of radiation therapy, contributing to wider adoption.
The market is categorized by type into internal radiation therapy, external beam radiation therapy, and systemic radiation therapy. External beam radiation therapy accounted for USD 4.6 billion in revenue in 2023 and is projected to grow at a CAGR of 5.6% during the forecast period. The segment includes intensity-modulated radiation therapy, image-guided radiation therapy, and proton therapy, among others. Growing cases of localized cancers, including breast, prostate, lung, and colorectal cancers, are fueling demand for this segment. Technological advancements in external beam radiation therapy continue to enhance treatment outcomes, driving further market growth.
By application, radiotherapy is used for treating various cancers, including lung, prostate, breast, cervical, and head and neck cancers. Breast cancer accounted for the highest revenue, reaching USD 2 billion in 2023, with a 28.8% market share. The increasing global burden of breast cancer continues to propel the adoption of radiotherapy as a primary treatment option.
The market is further segmented by end use, including hospitals, radiotherapy centers, ambulatory surgery centers, and cancer research institutes. Hospitals generated the highest revenue of USD 2.9 billion in 2023, as they offer advanced radiotherapy solutions and serve as a comprehensive hub for cancer treatment. The availability of cutting-edge radiotherapy equipment and integrated treatment options in hospitals solidifies their leading position in the industry. Collaborations between hospitals and radiotherapy system manufacturers are also accelerating advancements in treatment technology.
Regionally, North America remains a key revenue generator, with the market expected to reach USD 4.1 billion by 2032. The United States led the regional market with revenues of USD 2.4 billion in 2023, driven by a high prevalence of cancer cases and strong healthcare infrastructure. The increasing adoption of advanced radiotherapy solutions across hospitals and specialized treatment centers further boosts market expansion.
This product will be delivered within 2-4 business days.
The rising incidence of cancer worldwide is a primary driver behind the market’s growth. Increasing awareness of advanced cancer treatments, including radiotherapy, is further supporting market expansion. Continuous technological advancements are improving the precision and efficiency of radiation therapy, contributing to wider adoption.
The market is categorized by type into internal radiation therapy, external beam radiation therapy, and systemic radiation therapy. External beam radiation therapy accounted for USD 4.6 billion in revenue in 2023 and is projected to grow at a CAGR of 5.6% during the forecast period. The segment includes intensity-modulated radiation therapy, image-guided radiation therapy, and proton therapy, among others. Growing cases of localized cancers, including breast, prostate, lung, and colorectal cancers, are fueling demand for this segment. Technological advancements in external beam radiation therapy continue to enhance treatment outcomes, driving further market growth.
By application, radiotherapy is used for treating various cancers, including lung, prostate, breast, cervical, and head and neck cancers. Breast cancer accounted for the highest revenue, reaching USD 2 billion in 2023, with a 28.8% market share. The increasing global burden of breast cancer continues to propel the adoption of radiotherapy as a primary treatment option.
The market is further segmented by end use, including hospitals, radiotherapy centers, ambulatory surgery centers, and cancer research institutes. Hospitals generated the highest revenue of USD 2.9 billion in 2023, as they offer advanced radiotherapy solutions and serve as a comprehensive hub for cancer treatment. The availability of cutting-edge radiotherapy equipment and integrated treatment options in hospitals solidifies their leading position in the industry. Collaborations between hospitals and radiotherapy system manufacturers are also accelerating advancements in treatment technology.
Regionally, North America remains a key revenue generator, with the market expected to reach USD 4.1 billion by 2032. The United States led the regional market with revenues of USD 2.4 billion in 2023, driven by a high prevalence of cancer cases and strong healthcare infrastructure. The increasing adoption of advanced radiotherapy solutions across hospitals and specialized treatment centers further boosts market expansion.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2023
Chapter 5 Market Estimates and Forecast, by Type, 2021-2032 ($ Mn)
Chapter 6 Market Estimates and Forecast, by Application, 2021-2032 ($ Mn)
Chapter 7 Market Estimates and Forecast, by End Use, 2021-2032 ($ Mn)
Chapter 8 Market Estimates and Forecast, by Region, 2021-2032 ($ Mn)
Chapter 9 Company Profiles
Companies Mentioned
The companies featured in this Radiotherapy market report include:- Accuray
- Brainlab
- Curium
- Canon Medical Systems
- Elekta
- Hitachi High-Tech
- IBA Radiopharma Solutions
- Isoray Inc.
- Mevion Medical Systems
- Mitsubishi Electric
- Nordion
- NTP Radioisotopes
- RefleXion
- Toshiba Energy Systems & Solutions
- Varian Medical Systems
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 128 |
| Published | February 2025 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 7 Billion |
| Forecasted Market Value ( USD | $ 11.4 Billion |
| Compound Annual Growth Rate | 5.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 16 |
